Navigation Links
Simons Foundation awards Emory scientists $3M for autism gene research
Date:10/4/2007

The Simons Foundation has awarded scientists at Emory University School of Medicine a three-year grant of more than $3 million to uncover genes on the X chromosome that may contribute to the development of autism.

Stephen T. Warren, PhD, chair of the Emory Department of Human Genetics, is principal investigator of the program project that also includes Michael Zwick, PhD, and Brad Coffee, PhD, both Emory faculty members in human genetics.

Autism occurs four to nine times more frequently in males than in females, and genes on the X chromosome have long been suspected as being responsible for this male predilection. However, the ability to comprehensively examine the entire X chromosome for abnormalities has not been technically feasible until now.

Using technologies recently developed in the Department of Human Genetics, the Emory scientists will carry out a comprehensive search for genetic abnormalities of the X chromosome in 330 patients with autism.

The first project will scan the entire length of the X chromosome for subtle deletions or duplications using high-resolution microarrays containing short DNA fragments that can interrogate 2.1 million sites on the X chromosome. The second project will sequence all of the 1,098 genes on the X chromosome using a "next generation" DNA sequencing instrument. The final project will scan the entire X chromosome for evidence of "epigenetic" abnormalities, which are due to differences in gene expression rather than changes in the DNA itself.

This exhaustive survey of the human X chromosome should identify X-linked variation for autism susceptibility if such variation exists, says Dr. Warren.

"The unique genomic technologies available at Emory allow studies that would have been incomprehensible only a few years ago and will enable us to examine the 155 million bases of the X chromosome in minute detail in patients with autism," he explains.

Finding a predisposing gene is considered the most important first step to uncovering the true basis of a disease and to developing diagnostic tests and therapeutic approaches.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related biology news :

1. W.M. Keck Foundation funds study of friendly microbes
2. Digging in the dirt for lifes biochemical foundations
3. Protein folding: Building a strong foundation
4. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
5. Researchers Uncover Key Step In Manufacture of Memory Protein
6. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
7. Nanogen Issued Patent for Electronic Microarray With Memory
8. Rats infected as newborns grew up vulnerable to memory problems during an immune challenge
9. Structure-building cell signals also may influence learning and memory
10. Mice brains shrink during winter, impairing some learning and memory
11. Montreal researchers probe the genetic basis of memory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... LEAWOOD, Kan. , Feb. 22, 2017  Aratana Therapeutics, ... licensing, development and commercialization of innovative biopharmaceutical products for companion ... 14, 2017 at 8:30 a.m. ET to discuss financial results ... 2016. Interested participants and investors may access ... dial-in: ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
(Date:2/22/2017)... Toronto, ON (PRWEB) , ... February 22, 2017 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... trials validate the ProMIS approach.” This is one of a series of commentaries ...
Breaking Biology Technology: